In epithelial cell culture, it is upregulated by IL-17A, but previous studies have convincingly shown its decrease in psoriatic lesions and suggested this as a useful biomarker for the differentiation of psoriasis from atopic dermatitis in complicated differential diagnostic cases15. The gene discussed is IL17A; the disease is atopic eczema.